Suzanne Arinsburg
Overview
Explore the profile of Suzanne Arinsburg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Avigan Z, Arinsburg S, Pan D, Mark T, Fausel C, Bubalo J, et al.
Bone Marrow Transplant
. 2024 Oct;
60(1):115.
PMID: 39424960
No abstract available.
2.
Avigan Z, Arinsburg S, Pan D, Mark T, Fausel C, Bubalo J, et al.
Bone Marrow Transplant
. 2024 Jul;
59(10):1440-1448.
PMID: 39085373
Autologous stem cell transplantation is a standard treatment strategy for patients with multiple myeloma that requires effective mobilization and apheresis of peripheral blood progenitor cells; however, in the current era...
3.
Hernandez M, Buckley A, Mills A, Meislin R, Cromwell C, Bianco A, et al.
Transfusion
. 2023 Nov;
63(12):2384-2391.
PMID: 37952246
Background: Glanzmann thrombasthenia (GT) is a rare, autosomal recessive disorder of platelet glycoprotein IIb-IIIa receptors. Pregnant patients with GT are at increased risk of maternal and fetal bleeding. There is...
4.
Hernandez M, Riollano-Cruz M, Boyle M, Banu R, Shrestha P, Gray B, et al.
J Med Virol
. 2022 Feb;
94(6):2471-2478.
PMID: 35171508
Saliva is a promising specimen for the detection of viruses that cause upper respiratory infections including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) due to its cost-effectiveness and noninvasive collection....
5.
Diaz K, Tremblay D, Ozturk B, Ezaz G, Arinsburg S, Jhang J, et al.
Blood Coagul Fibrinolysis
. 2021 Aug;
32(7):468-472.
PMID: 34334702
Patients with cirrhosis have coagulopathy often necessitating correction with blood products, such as plasma products (fresh frozen plasma and plasma frozen within 24 h) prior to certain invasive procedures. However,...
6.
Oguntuyo K, Stevens C, Hung C, Ikegame S, Acklin J, Kowdle S, et al.
mBio
. 2021 Feb;
12(1).
PMID: 33593976
The global coronavirus disease 2019 (COVID-19) pandemic has mobilized efforts to develop vaccines and antibody-based therapeutics, including convalescent-phase plasma therapy, that inhibit viral entry by inducing or transferring neutralizing antibodies...
7.
Klingler J, Weiss S, Itri V, Liu X, Oguntuyo K, Stevens C, et al.
J Infect Dis
. 2020 Dec;
223(6):957-970.
PMID: 33367897
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people globally. Virus infection requires the receptor-binding domain (RBD) of the spike protein. Although studies have demonstrated anti-spike...
8.
Klingler J, Weiss S, Itri V, Liu X, Oguntuyo K, Stevens C, et al.
medRxiv
. 2020 Nov;
PMID: 33173891
Background: SARS-CoV-2 has infected millions of people globally. Virus infection requires the receptor-binding domain (RBD) of the spike protein. Although studies have demonstrated anti-spike and - RBD antibodies to be...
9.
Lee W, Girardin R, Dupuis A, Kulas K, Payne A, Wong S, et al.
J Infect Dis
. 2020 Oct;
223(1):47-55.
PMID: 33104179
Passive transfer of antibodies from COVID-19 convalescent patients is being used as an experimental treatment for eligible patients with SARS-CoV-2 infections. The United States Food and Drug Administration's (FDA) guidelines...
10.
Wajnberg A, Mansour M, Leven E, Bouvier N, Patel G, Firpo-Betancourt A, et al.
Lancet Microbe
. 2020 Oct;
1(7):e283-e289.
PMID: 33015652
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. The proportion of infected individuals who seroconvert is still an open question. In addition, it has been...